122647-36-3

Upstream product

• 122624-86-6 (4S,5R)-4-<(Benzyloxy)methoxy>dihydro-5-methyl-5-(4-methyl-3-pentenyl)-2(3H)-furanone 
• 122624-87-7 (4S,5R)-4-<(Benzyloxy)methoxy>-2-hydroxy-5-methyl-5-(4-methyl-3-pentenyl)tetrahydrofuran 
• 122624-85-5 (4S,5R)-5-(4'-methyl-3'-pentenyl)-4-hydroxy-5-methyldihydrofuran-2-one 
• 122624-89-9 Ethyl (2E,5S,6R)-5-<(benzyloxy)methoxy>-6-hydroxy-2,6,10-trimethyl-2,9-undecadienoate 
• 18156-74-6 1-(Trimethylsilyl)imidazole 

Downstream Products

• 122625-02-9 (βR,γR,2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-β,γ-epoxytetrahydro-β,2,6-trimethyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)-2H-pyran-2-butanol 
• 122625-02-9 (2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2,6-dimethyl-2-<(2S,3S)-2,3-epoxy-4-hydroxy-3-methylbutyl>-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)tetrahydro-2H-pyran 
• 122624-84-4 3,7:6,10-Dianhydro-9-O-<(benzyloxy)methyl>-13-O-(tert-butyldimethylsilyl)-1,2,5,8,11,12-hexadeoxy-3,6,10-tri-C-methyl-4-O-(trimethylsilyl)-1-(triphenylphosphonio)-D-erythro-D-allo-tridecitol iodide 
• 122625-11-0 (2S,3R,4aS,6R,7S,8aR)-7-<(Benzyloxy)methoxy>-6-<3-(tert-butyldimethylsiloxy)propyl>-2-(2-iodoethyl)-2,4a,6-trimethyl-3-(trimethylsiloxy)perhydropyrano<3,2-b>pyran 
• 122625-00-7 Ethyl 4-<(2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2,6-dimethyl-2-ethynyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)tetrahydro-2H-pyran-2-yl>-(2E)-crotonate 
• 122648-31-1 (2S,3R,4aS,6R,7S,8aR)-7-<(Benzyloxy)methoxy>octahydro-2,4a,6-trimethyl-3-(trimethylsiloxy)-6-(4-methyl-3-pentenyl)-2-vinylpyrano<3,2-b>pyran 
• 122625-03-0 (2R,3R)-4-<(2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2,6-dimethyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)tetrahydro-2H-pyran-2-yl>-2,3-epoxy-3-methylbutyraldehyde 
• 122625-08-5 (2S,3R,5aS,6R,7S,8aR)-7-<(Benzyloxy)methoxy>octahydro-2,4a,6-trimethyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)pyrano<3,2-b>pyran-2-ethanol 
• 122625-09-6 (2S,3R,4aS,6R,7S,8aR)-7-<(Benzyloxy)methoxy>-2-(2-iodoethyl)-6-(4-methyl-3-pentenyl)-2,4a,6-trimethyl-3-(trimethylsiloxy)perhydropyrano<3,2-b>pyran 
• 122625-06-3 (2S,3R,4aS,6R,7S,8aR)-7-<(Benzyloxy)methoxy>octahydro-2,4a,6-trimethyl-3-acetoxy-6-(4-methyl-3-pentenyl)-2-vinylpyrano<3,2-b>pyran 
• 122625-04-1 (2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2-<(2R,3R)-2,3-epoxy-3-methyl-4-pentenyl>tetrahydro-2,6-dimethyl-6-(4-methyl-3-pentenyl)-2H-pyran-3-ol 
• 122625-01-8 4-<(2S,3R,5S,6R)-5-<(Benzyloxy)methoxy>-2,6-dimethyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)tetrahydro-2H-pyran-2-yl>-(2E)-crotyl alcohol 
• 122625-10-9 (2S,3R,4aS,6R,7S,8aR)-7-<(Benzyloxy)methoxy>-6-(3-hydroxypropyl)-2-(2-iodoethyl)-2,4a,6-trimethyl-3-(trimethylsiloxy)perhydropyrano<3,2-b>pyran 
• 122624-97-9 (2S,3R,6R)-5-<(Benzyloxy)methoxy>-2-<(Z)-2-chlorovinyl>-2,6-dimethyl-6-(4-methyl-3-pentenyl)-3-(trimethylsiloxy)tetrahydro-2H-pyran 

Relevant academic research and scientific papers

Synthesis of the FG Ring System of Brevetoxin B

A synthesis of an appropriately functionalized system (1) representing the FG ring skeleton of brevetoxin B is described.Beginning with the geraniol-derived lactone 6, the reported sequence proceeds via key intermediates 15 and 27 and involves two 6-endo selective hydroxy epoxide openings leading to the optically active target 1.The stereochemistry of the final product was confirmed by an X-ray crystallographic analysis of the crystalline derivative 30.